Biologische Marker des Alkoholismus und alkoholassoziierter Organschäden
Publisher
Springer-Verlag
Reference35 articles.
1. Allen JP, Fertig JB, Litten RZ, Sillanaukee P, Anton RF (1997) Proposed recommendations for research on biochemical markers for problematic drinking. Alc Clin Exp Res 21: 244–247
2. Anton RF, Lieber C, Tabakoff B — CDTect study group (2002) Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alc Clin Exp Res 26: 1215–1222
3. Bell H, Tallasen CME, Try K, Haug E (1994) Carbohydrate-Deficient Transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alc Clin Exp Res 18: 1103–1108
4. Bleich S, Bandelow B, Javaheripour K et al. (2003) Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism. Neurosci Lett 335: 179–182
5. Breyer-Pfaff U, Wiatr G, Stevens I, Gaertner HJ, Mundle G, Mann K (1996) Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking. Life Sci 58: 1425–1432